Downregulation of Fas ligand by shedding

M Tanaka, T Itai, M Adachi, S Nagata - Nature medicine, 1998 - nature.com
M Tanaka, T Itai, M Adachi, S Nagata
Nature medicine, 1998nature.com
Abstract Apoptosis-inducing Fas ligand (FasL) is a type II membrane protein, predominantly
expressed in the activated T cells. FasL is cleaved by a putative metalloproteinase to
produce a soluble form. Here, we blocked the shedding of human FasL by deleting its
cleavage site. Although human Jurkat cells and mouse primary hepatocytes that express a
low level of Fas were resistant to the soluble form of FasL, they were efficiently killed by
membrane-bound FasL. Furthermore, soluble FasL inhibited cytotoxicity of the membrane …
Abstract
Apoptosis-inducing Fas ligand (FasL) is a type II membrane protein, predominantly expressed in the activated T cells. FasL is cleaved by a putative metalloproteinase to produce a soluble form. Here, we blocked the shedding of human FasL by deleting its cleavage site. Although human Jurkat cells and mouse primary hepatocytes that express a low level of Fas were resistant to the soluble form of FasL, they were efficiently killed by membrane-bound FasL. Furthermore, soluble FasL inhibited cytotoxicity of the membrane-bound FasL. These results indicate that the membrane-bound form of FasL is the functional form and suggest that shedding of FasL is to prevent the killing of the healthy bystander cells by cytotoxic T cells.
nature.com